These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 626876)

  • 1. A biochemical and morphological study of the altered growth pattern of central catecholamine neurons following 6-hydroxydopamine.
    Konkol RJ; Bendeich EG; Breese GR
    Brain Res; 1978 Jan; 140(1):125-35. PubMed ID: 626876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in brain norepinephrine content in mice following neonatal 6-hydroxydopamine.
    Lovell KL
    Brain Res Bull; 1981 Jul; 7(1):41-4. PubMed ID: 7272787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regenerative critical periods for locus coeruleus in postnatal rat pups following intracisternal 6-hydroxydopamine: a model of noradrenergic development.
    Schmidt RH; Kasik SA; Bhatnagar RK
    Brain Res; 1980 Jun; 191(1):173-90. PubMed ID: 7378749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional depletion of central nervous system catecholamines: effects on blood pressure and drinking behavior.
    Gordon FJ; Brody MJ; Johnson AK
    Brain Res; 1985 Oct; 345(2):285-97. PubMed ID: 3930004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional development of norepinephrine, dopamine-beta-hydroxylase and tyrosine hydroxylase in the rat brain subsequent to neonatal treatment with subcutaneous 6-hydroxydopamine.
    Schmidt RH; Bhatnagar RK
    Brain Res; 1979 Apr; 166(2):293-308. PubMed ID: 34468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracisternal dose-response analysis of 6-hydroxydopamine-induced noradrenergic sprouting in the neonatal rat cerebellum.
    Schmidt RH; Bhatnagar RK
    J Pharmacol Exp Ther; 1980 Mar; 212(3):456-61. PubMed ID: 7359347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal intraspinal 6-hydroxydopamine: depletion of norepinephrine but not dopamine.
    Ings R; Pappas B
    Eur J Pharmacol; 1981 Apr; 70(4):577-83. PubMed ID: 6263641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of intraperitoneal injection of 6-hydroxydopamine on the turnover and the levels of the brain catecholamines and the levels of plasma corticosterone in rats.
    Kawa A; Kamisaki T; Ariyama T; Kawabata T; Maeda Y; Okamoto O; Kanehisa T
    Clin Exp Pharmacol Physiol; 1979; 6(2):123-8. PubMed ID: 421367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of intracranial injections of 6-OHDA and guanethidine on consummatory behavior and monoamine depletion.
    Singer G; Armstrong S; Evans B; Burnstock G
    Pharmacol Biochem Behav; 1975; 3(1 Suppl):91-106. PubMed ID: 1226403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of neonatal 6-hydroxydopamine treatment on catecholamine levels and behavior during development and adulthood.
    Fobes JL; Olds ME
    Psychopharmacology (Berl); 1981; 73(1):27-30. PubMed ID: 6785785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intraventricular injection of 6-hydroxydopamine in the developing kitten. II. On the central monoaminergic innervation.
    Bourgoin S; Adrien J; Laguzzi RF; Dolphin A; Bockaert J; Hery F; Hamon M
    Brain Res; 1979 Jan; 160(3):461-78. PubMed ID: 421125
    [No Abstract]   [Full Text] [Related]  

  • 13. Catecholamine release by intracerebral perfusion of 6-hydroxydopamine and desipramine.
    Martin GE; Myers RD; Newberg DC
    Eur J Pharmacol; 1976 Apr; 36(2):299-311. PubMed ID: 1278225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disappearance and recovery of catecholamine innervation in brain regions of adult goldfish following 6-hydroxydopamine treatment.
    Contestabile A; Friz T; Caravaggio MV
    Neurosci Lett; 1979 Oct; 14(2-3):333-7. PubMed ID: 530509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the migrating myoelectric complex by brain noradrenergic systems in rats.
    Bonaz B; Martin L; Beurriand E; Manier M; Hostein J; Feuerstein C
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G340-5. PubMed ID: 1899972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of hypertrophied locus coeruleus projection to adult cerebellum after neonatal 6-hydroxydopamine.
    Schmidt RH; Bhatnagar RK
    Brain Res; 1979 Aug; 172(1):23-33. PubMed ID: 466465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects on body weight of central 6-hydroxydopamine lesions in obese (ob/ob) and diabetes (db/db) mice.
    Lorden JF
    J Comp Physiol Psychol; 1979 Dec; 93(6):1085-96. PubMed ID: 521520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of depletion of spinal noradrenaline by 6-hydroxydopamine on the development of renal hypertension in rats.
    Bosland MC; Versteeg DH; van Put J; de Jong W
    Clin Exp Pharmacol Physiol; 1981 Jan; 8(1):67-77. PubMed ID: 7471522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supersensitivity of the noradrenergic system in the spinal cord following intracisternal injection of 6-hydroxydopamine.
    Jones DJ; Alcantara OF; Ademe RM
    Neuropharmacology; 1984 Apr; 23(4):431-8. PubMed ID: 6145115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological evidence for 6-hydroxydopamine-induced sprouting or noradrenergic neurons in the cerebellum.
    Bendeich E; Konkol RJ; Krigman MR; Breese GR
    J Neurol Sci; 1978 Aug; 38(1):47-57. PubMed ID: 702183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.